Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre Study to Define Novel Individualised Dosing Regimens to Maximise Antibiotic Effectiveness for Treatment of Pneumonia in Intensive Care Units

NCT04986254 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT04986254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04986254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre Study to Define Novel Individualised Dosing Regimens to Maximise Antibiotic Effectiveness for Treatment of Pneumonia in Intensive Care Units
Lead sponsor
The University of Queensland
Phase
Observational
Overall status
Completed
Start date
October 17, 2019
Completion date
January 31, 2024
Enrollment
179 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia